Journals / Dicle Tıp Dergisi / 2004 / Cilt: 31 - Sayı: 4

Gebelik sürecinde valproik asitin karaciğer dokusundaki toksik etkilerine karşı folik asit ve vitamin E'nin koruyucu rolü

The protective role of folic acid and vitamin E against toxical effects of valproic acid on liver tissue during period of gestation

Pages
17–23
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Under these source of results, we viewed antioxidants decreased the hepatotoxicity on liver tissue by using folic acid and vitamin E .

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Valproic acid is an anticonvulsan drug used in epilepsy.
📊
Key Findings & Data:The histopathological changes of valproic acid on liver and the protective effect of vitamin E and also folic acid were observed. 24 adult female Wistar Albino rats were used.
💡
Conclusion & Impact:Under these source of results, we viewed antioxidants decreased the hepatotoxicity on liver tissue by using folic acid and vitamin E .
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Folik asit · Karaciğer · Gebelik

Abstract

Valproic acid is an anticonvulsan drug used in epilepsy. The histopathological changes of valproic acid on liver and the protective effect of vitamin E and also folic acid were observed. 24 adult female Wistar Albino rats were used. The first control, the second valproic acid group that was given 300 mg/kg on 8.9. and 10. days of gestation, the third valproic acid +vitamin E group. Vitamin E was given 250mg/kg via nasogastric intubation before one hour administration of valproic acid on 8.9.10.days of gestation. The fourth valproic acid+ folic acid group; via valproic acid, folic acid was given 400 microgram ordinarily in drinking water per day. In the liver sections of valproic acid group, perivenullar dilatation, swelling of Kuppfer cells, microvesicular steatosis and degeneration were observed. In the second group there was moderate degeneration in hepatocytes,necrotic areas in some places, mononuclear cell infiltration. In valproic acid +vitamin E group normal-like appearance of the structure of Remark cell lines were observed. Under these source of results, we viewed antioxidants decreased the hepatotoxicity on liver tissue by using folic acid and vitamin E .

Özet

Valproik asit epilepside kullanılan antikonvülzan bir ilaçtır. Valproik Asit’in karaciğer üzerinde yaptığı histopatolojik değişiklikler ile folik asit ve vitamin E’nin koruyucu etkileri incelendi. 24 erişkin dişi Wistar Albino tipi sıçan kullanıldı. Birinci grup kontrol, ikinci grup gebeliğin 8.9. ve 10. günlerinde 300mg/kg dozunda valproik asit verilen grup, üçüncü grup valproik asit+vitamin E grubuydu. Vitamin E, valproik asit uygulamasından bir saat önce 250mg/kg dozunda nazogastrik intübasyonla yine gebeliğin 8.9.10.günlerinde verildi. Dördüncü valproik asit+folik asit grubuna valproik asit yanında, içme suyuna düzenli olarak her gün 400 mikrogram dozunda folik asit katıldı. Valproik asit grubunun karaciğer kesitlerinde perivenüller dilatasyon, Kuppfer hücre şişmesi, mikroveziküler steatozis ve dejenerasyon izlendi. Üçüncü grubun hepatositlerinde orta derecede dejenerasyon, bazı yerlerde nekrotik alanlar ve mononükleer hücre infiltrasyonu görüldü. Dördüncü grupta Remark hücre kordonlarının görünümü normale yakındı. Bu bulguların ışığı altında folik asit ve vitamin E kullanarak antioksidanların hepatotoksisiteyi azalttığını izledik.

🔖

Cite This Article

BARAN, P. Ö., YILDIRIM, A., AKKUŞ, M. (2004). Gebelik sürecinde valproik asitin karaciğer dokusundaki toksik etkilerine karşı folik asit ve vitamin E'nin koruyucu rolü. Dicle Tıp Dergisi, Cilt: 31 - Sayı: 4, 17–23. https://ajindex.com/articles/349417

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Löscler W.H., Nau U., Wahnshaffe D., Hönack C., Rundfeldt W., Wittfoht & Bojic U. Effect of valproate and E-2-en-valproate on functional and morfological parameters of rat liver.II. İnfluence of phenobarbital comedication. Epilepsy. Res. 1993;15: 113-131
  2. Rettie A.E.,Boberg M.,Rettenmeier W.A.&Baillie A.T. Cytochroma P-450- catalyzed desaturation of valproic acid in vitro. J. Biol. Chem.1988;263:13733-13738
  3. Buchi K.N., Gray P.D., Rollins D.E., Tolman K.G. Protection against sodium valproate ıngury in isolated hepatocytes by alfa-Tocopherol and N.N-Diphenyl-p-phenylenediamine. J.Clin. Pharmacol. 1984;24:148-154
  4. Suchy FJ, Balistereri WF., Buchino J.J. et al. Acute hepatic failure associated with the use of sodıum valproate. N. Engl. J. Med. 1979:300-962
  5. Ware S., Millward-Sadler G.H. Acute liver disease associated with sodium valproate, Lancet.1980;2:1110-1980
  6. Reynolds JEF., Parfitt K., Parsons A.V., Sweetman S.C. editors. Folic Acid. Martindale:The extra Pharmacopoeia. 31sted. London: The Royal Pharmaceutical Society, 1996: 1361-1362
  7. Jurima-Romet M., Abbott F.S., Tang. W., Huang H.S.,Whitehouse L.W. Cytotoxicity of unsaturated metabolites of valproic acid and protection by vitamins C and E in glutathionedepleted rat hepatocytes. Toxicology. 1996;112:69-85
  8. Zimmerman HJ, Ihsak KG. Valproateinduced hepatic injury: analyses of 23 fatal cases. Hepatology.1982;2:591-597
  9. Fenichel GM, Grene HL. Valproate hepatotoxicity: two new cases, a summary of other and recommendations. Pediatr Neural. 1985;1:109-113
  10. Zafrani ES, Berthelot P.Sodium valproate in the induction of unusal hepatotoxicity. Hepatology 1982;2:648-649
  11. Becker C.M., Harris R.A. Influence of valproic acid on hepatic carbonhydrate and lipid metabolism. Arch. Biochem. Biophys.1983;223:381-392
  12. Beers R.F., Sizer W. A spectrophotometric method for measurement the breakdown of hydrogen peroxide by catalase. J. Biol. Chem.1951;195:133-140
  13. Seçkin Ş., Başaran-Küçükgergin C., Uysal M. Effect of acute and chronic administration of sodium valproate on lipid peroxidation and antioxidant system in rat liver. Pharmacol. Toxicol.1999;85:294-298
  14. Daffron J.C. and Kasarkis E.J. Effect of valproic acid on zinc metabolism in the rat. Toxicol. Lett. 1984;23:321
  15. Keen C.L., Peters J.M. and Hurley L.S. The effect of valproic acid on Zn distribution in the pregnant rat. J. Nutr.1989:119- 607
  16. Browne TR.Valproic acid. N Engl J Med. 1980; 20;302(12):661-6
  17. Zimmer